>
pdufa.bio

Povorcitinib

Updated ยทnext FDA decision on the calendar

Povorcitinib is a Incyte Corp program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

INCY catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Incyte Corp (INCY). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026INCY

Questions

When is Povorcitinib's next FDA decision or readout?

The next tracked catalyst for Povorcitinib is a Readout in Oct 2026.

What happened at Povorcitinib's most recent FDA decision?

No FDA decision for Povorcitinib is in our archive yet.

Who makes Povorcitinib?

Incyte Corp (INCY).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.